Solithromycin

Solithromycin (trade name Solithera) is a ketolideantibiotic undergoing clinical development for the treatment of community-acquired pneumonia and other infections.

Solithromycin exhibits excellent in vitro activity against a broad spectrum of Gram-positiverespiratory tractpathogens, including macrolide-resistant strains. Solithromycin has activity against most common respiratory Gram-positive and fastidious Gram-negative pathogens, and is being evaluated for its utility in treating gonorrhea.